Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 341-350 of 406 for multiple

Edit search filters
  1. A Study To Evaluate The Adverse Events, And Efficacy Of Intravenous (IV) Of Telisotuzumab Adizutecan In Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab In Adult Participants With Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. Safety Study Of OA-235i In Subjects With Nonalcoholic Steatohepatitis

    Rochester, MN

  3. Dose Escalation Study In Patients With Relapsed Or Refractory DLBCL And MyD88 L265P Mutation

    Rochester, MN

  4. Safety, Tolerability And Pharmacokinetics Of AZD1613 In Adults With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  5. A Study Of Obinutuzumab To Evaluate The Safety And Tolerability In Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation

    Rochester, MN

  6. AMX0114 In Adult Participants With Amyotrophic Lateral Sclerosis

    Jacksonville, FL, Rochester, MN

  7. Safety And Efficacy Study Of TX103 CAR-T Cell Therapy For Recurrent Or Progressive Grade 4 Glioma.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. VG161 In The Treatment Of Patients With Hepatocellular Carcinoma Or Intrahepatic Cholangiocarcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study Of RGLS8429 In Patients With Autosomal Dominant Polycystic Kidney Disease

    Jacksonville, FL, Rochester, MN

  10. Evaluation of a Clinical Tool to Assess Patient Treatment Experience and Self-Management (PETS-Now)

    Rochester, MN

.

Mayo Clinic Footer